HEADER TRANSFERASE 19-FEB-15 4YC8 TITLE C-HELIX-OUT BINDING OF DASATINIB ANALOG TO C-ABL KINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 248-531; COMPND 5 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 6 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS KINASE, C-HELIX-OUT, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR F.E.KWARCINSKI,K.B.BRANDVOLD,T.J.JOHNSON,S.PHADKE,J.L.MEAGHER, AUTHOR 2 M.A.SEELIGER,J.A.STUCKEY,M.B.SOELLNER REVDAT 3 27-SEP-23 4YC8 1 REMARK REVDAT 2 01-JUN-16 4YC8 1 JRNL REVDAT 1 02-MAR-16 4YC8 0 JRNL AUTH F.E.KWARCINSKI,K.R.BRANDVOLD,S.PHADKE,O.M.BELEH,T.K.JOHNSON, JRNL AUTH 2 J.L.MEAGHER,M.A.SEELIGER,J.A.STUCKEY,M.B.SOELLNER JRNL TITL CONFORMATION-SELECTIVE ANALOGUES OF DASATINIB REVEAL INSIGHT JRNL TITL 2 INTO KINASE INHIBITOR BINDING AND SELECTIVITY. JRNL REF ACS CHEM.BIOL. V. 11 1296 2016 JRNL REFN ESSN 1554-8937 JRNL PMID 26895387 JRNL DOI 10.1021/ACSCHEMBIO.5B01018 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 3 NUMBER OF REFLECTIONS : 17477 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.880 REMARK 3 FREE R VALUE TEST SET COUNT : 1028 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.64 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1672 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2145 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1553 REMARK 3 BIN R VALUE (WORKING SET) : 0.2058 REMARK 3 BIN FREE R VALUE : 0.3315 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 119 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4073 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 105 REMARK 3 SOLVENT ATOMS : 11 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.09 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.91420 REMARK 3 B22 (A**2) : -0.19550 REMARK 3 B33 (A**2) : -3.71870 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.363 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.506 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.344 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 2.004 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.348 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.909 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.863 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4380 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6046 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1920 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 90 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 709 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4380 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 552 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4965 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.04 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.98 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.80 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|233 - 501} REMARK 3 ORIGIN FOR THE GROUP (A): 10.7905 43.8378 13.3548 REMARK 3 T TENSOR REMARK 3 T11: 0.0600 T22: -0.0382 REMARK 3 T33: -0.1340 T12: 0.0823 REMARK 3 T13: 0.0089 T23: -0.0037 REMARK 3 L TENSOR REMARK 3 L11: 0.5752 L22: 0.6586 REMARK 3 L33: 1.9104 L12: -0.1063 REMARK 3 L13: -0.2824 L23: 0.2263 REMARK 3 S TENSOR REMARK 3 S11: 0.0084 S12: -0.0043 S13: 0.0316 REMARK 3 S21: -0.1244 S22: -0.0414 S23: 0.0290 REMARK 3 S31: 0.0591 S32: 0.1144 S33: 0.0331 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {B|233 - 502} REMARK 3 ORIGIN FOR THE GROUP (A): 39.2163 18.7101 13.8718 REMARK 3 T TENSOR REMARK 3 T11: -0.0625 T22: -0.0152 REMARK 3 T33: -0.0235 T12: 0.1003 REMARK 3 T13: -0.0457 T23: 0.0322 REMARK 3 L TENSOR REMARK 3 L11: 0.9066 L22: 2.1899 REMARK 3 L33: 0.4217 L12: -0.0009 REMARK 3 L13: -0.5723 L23: -0.0908 REMARK 3 S TENSOR REMARK 3 S11: -0.0110 S12: -0.0342 S13: 0.0883 REMARK 3 S21: 0.0566 S22: -0.0703 S23: -0.0687 REMARK 3 S31: -0.0086 S32: -0.0339 S33: 0.0814 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4YC8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1000207194. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18959 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.51700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2G1T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 6.5, 22% PEG 3350, 100 MM REMARK 280 NAOAC, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 56.38000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 63.55000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 56.38000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 63.55000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 226 REMARK 465 HIS A 227 REMARK 465 MET A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 TYR A 232 REMARK 465 GLY A 249 REMARK 465 GLY A 250 REMARK 465 GLY A 251 REMARK 465 GLN A 252 REMARK 465 TYR A 253 REMARK 465 GLY A 254 REMARK 465 LYS A 274 REMARK 465 GLU A 275 REMARK 465 ASP A 276 REMARK 465 THR A 277 REMARK 465 ILE A 502 REMARK 465 SER A 503 REMARK 465 ASP A 504 REMARK 465 GLU A 505 REMARK 465 VAL A 506 REMARK 465 GLU A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 GLY A 511 REMARK 465 LYS A 512 REMARK 465 GLY B 226 REMARK 465 HIS B 227 REMARK 465 MET B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 TYR B 232 REMARK 465 GLY B 249 REMARK 465 GLY B 250 REMARK 465 GLY B 251 REMARK 465 GLN B 252 REMARK 465 TYR B 253 REMARK 465 GLY B 254 REMARK 465 SER B 503 REMARK 465 ASP B 504 REMARK 465 GLU B 505 REMARK 465 VAL B 506 REMARK 465 GLU B 507 REMARK 465 LYS B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 465 GLY B 511 REMARK 465 LYS B 512 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 ARG A 239 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 247 CG CD CE NZ REMARK 470 GLU A 255 CG CD OE1 OE2 REMARK 470 SER A 265 OG REMARK 470 LYS A 271 CG CD CE NZ REMARK 470 LEU A 273 CG CD1 CD2 REMARK 470 MET A 278 CG SD CE REMARK 470 GLU A 279 CG CD OE1 OE2 REMARK 470 GLU A 282 CG CD OE1 OE2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 294 CG CD CE NZ REMARK 470 ARG A 307 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 308 CG CD OE1 OE2 REMARK 470 PHE A 311 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 400 CG CD CE NZ REMARK 470 GLU A 459 CG CD OE1 OE2 REMARK 470 GLU A 462 CG CD OE1 OE2 REMARK 470 GLU A 466 CG CD OE1 OE2 REMARK 470 LYS A 467 CG CD CE NZ REMARK 470 GLN A 498 CG CD OE1 NE2 REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 GLU B 238 CG CD OE1 OE2 REMARK 470 LYS B 245 CG CD CE NZ REMARK 470 HIS B 246 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 247 CG CD CE NZ REMARK 470 LEU B 248 CG CD1 CD2 REMARK 470 GLU B 255 CG CD OE1 OE2 REMARK 470 LYS B 262 CG CD CE NZ REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 TYR B 264 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 SER B 265 OG REMARK 470 LEU B 266 CG CD1 CD2 REMARK 470 LYS B 271 CG CD CE NZ REMARK 470 LEU B 273 CG CD1 CD2 REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 GLU B 275 CG CD OE1 OE2 REMARK 470 GLU B 279 CG CD OE1 OE2 REMARK 470 GLU B 281 CG CD OE1 OE2 REMARK 470 GLU B 282 CG CD OE1 OE2 REMARK 470 LYS B 285 CG CD CE NZ REMARK 470 LYS B 294 CG CD CE NZ REMARK 470 ARG B 307 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 308 CG CD OE1 OE2 REMARK 470 GLN B 333 CG CD OE1 NE2 REMARK 470 LYS B 356 CG CD CE NZ REMARK 470 LYS B 357 CG CD CE NZ REMARK 470 ARG B 386 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 400 CG CD CE NZ REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 470 GLU B 466 CG CD OE1 OE2 REMARK 470 SER B 500 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 362 -2.63 70.16 REMARK 500 ASP A 363 53.57 -152.18 REMARK 500 ASN A 374 41.01 70.64 REMARK 500 TYR A 435 60.50 62.92 REMARK 500 GLU B 258 67.47 -101.19 REMARK 500 ASN B 336 -166.40 -108.39 REMARK 500 ARG B 362 -5.50 71.35 REMARK 500 ASP B 363 56.26 -148.90 REMARK 500 ASN B 414 17.85 54.80 REMARK 500 TRP B 476 39.63 -98.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 4B7 A 601 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4B7 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MES A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4B7 B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MES B 603 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4YBK RELATED DB: PDB DBREF 4YC8 A 229 512 UNP P00519 ABL1_HUMAN 248 531 DBREF 4YC8 B 229 512 UNP P00519 ABL1_HUMAN 248 531 SEQADV 4YC8 GLY A 226 UNP P00519 EXPRESSION TAG SEQADV 4YC8 HIS A 227 UNP P00519 EXPRESSION TAG SEQADV 4YC8 MET A 228 UNP P00519 EXPRESSION TAG SEQADV 4YC8 GLY B 226 UNP P00519 EXPRESSION TAG SEQADV 4YC8 HIS B 227 UNP P00519 EXPRESSION TAG SEQADV 4YC8 MET B 228 UNP P00519 EXPRESSION TAG SEQRES 1 A 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU SEQRES 2 A 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY SEQRES 3 A 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SEQRES 4 A 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR SEQRES 5 A 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET SEQRES 6 A 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY SEQRES 7 A 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU SEQRES 8 A 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU SEQRES 9 A 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR SEQRES 10 A 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU SEQRES 11 A 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 12 A 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP SEQRES 13 A 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR SEQRES 14 A 287 ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA SEQRES 15 A 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER SEQRES 16 A 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA SEQRES 17 A 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER SEQRES 18 A 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU SEQRES 19 A 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET SEQRES 20 A 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER SEQRES 21 A 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN SEQRES 22 A 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY SEQRES 23 A 287 LYS SEQRES 1 B 287 GLY HIS MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU SEQRES 2 B 287 ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY SEQRES 3 B 287 GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SEQRES 4 B 287 SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR SEQRES 5 B 287 MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET SEQRES 6 B 287 LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY SEQRES 7 B 287 VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU SEQRES 8 B 287 PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU SEQRES 9 B 287 CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR SEQRES 10 B 287 MET ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU SEQRES 11 B 287 LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN SEQRES 12 B 287 CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP SEQRES 13 B 287 PHE GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR SEQRES 14 B 287 ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA SEQRES 15 B 287 PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER SEQRES 16 B 287 ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA SEQRES 17 B 287 THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER SEQRES 18 B 287 GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU SEQRES 19 B 287 ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET SEQRES 20 B 287 ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER SEQRES 21 B 287 PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN SEQRES 22 B 287 GLU SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY SEQRES 23 B 287 LYS HET 4B7 A 601 59 HET EDO A 602 10 HET MES A 603 25 HET 4B7 B 601 67 HET EDO B 602 10 HET MES B 603 25 HETNAM 4B7 2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2- HETNAM 2 4B7 METHYLPYRIMIDIN-4-YL}AMINO)-N-(4-PHENOXYPHENYL)-1,3- HETNAM 3 4B7 THIAZOLE-5-CARBOXAMIDE HETNAM EDO 1,2-ETHANEDIOL HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN EDO ETHYLENE GLYCOL FORMUL 3 4B7 2(C27 H29 N7 O3 S) FORMUL 4 EDO 2(C2 H6 O2) FORMUL 5 MES 2(C6 H13 N O4 S) FORMUL 9 HOH *11(H2 O) HELIX 1 AA1 GLU A 238 THR A 240 5 3 HELIX 2 AA2 LYS A 263 SER A 265 5 3 HELIX 3 AA3 GLU A 279 MET A 290 1 12 HELIX 4 AA4 ASN A 322 CYS A 330 1 9 HELIX 5 AA5 ASN A 336 LYS A 357 1 22 HELIX 6 AA6 ALA A 365 ARG A 367 5 3 HELIX 7 AA7 PRO A 402 THR A 406 5 5 HELIX 8 AA8 ALA A 407 ASN A 414 1 8 HELIX 9 AA9 SER A 417 TYR A 435 1 19 HELIX 10 AB1 ASP A 444 SER A 446 5 3 HELIX 11 AB2 GLN A 447 LYS A 454 1 8 HELIX 12 AB3 PRO A 465 TRP A 476 1 12 HELIX 13 AB4 ASN A 479 ARG A 483 5 5 HELIX 14 AB5 SER A 485 SER A 500 1 16 HELIX 15 AB6 GLU B 279 ILE B 293 1 15 HELIX 16 AB7 ASN B 322 CYS B 330 1 9 HELIX 17 AB8 ASN B 336 LYS B 357 1 22 HELIX 18 AB9 ALA B 365 ARG B 367 5 3 HELIX 19 AC1 ALA B 407 ASN B 414 1 8 HELIX 20 AC2 SER B 417 TYR B 435 1 19 HELIX 21 AC3 ASP B 444 SER B 446 5 3 HELIX 22 AC4 GLN B 447 LYS B 454 1 8 HELIX 23 AC5 PRO B 465 TRP B 476 1 12 HELIX 24 AC6 ASN B 479 ARG B 483 5 5 HELIX 25 AC7 SER B 485 SER B 501 1 17 SHEET 1 AA1 5 ILE A 242 LYS A 247 0 SHEET 2 AA1 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 AA1 5 LEU A 266 LEU A 273 -1 O VAL A 270 N TYR A 257 SHEET 4 AA1 5 PHE A 311 GLU A 316 -1 O PHE A 311 N LEU A 273 SHEET 5 AA1 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 AA2 2 PHE A 359 ILE A 360 0 SHEET 2 AA2 2 SER A 385 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 AA3 2 CYS A 369 VAL A 371 0 SHEET 2 AA3 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 AA4 2 TYR A 393 THR A 394 0 SHEET 2 AA4 2 LYS A 415 PHE A 416 -1 O PHE A 416 N TYR A 393 SHEET 1 AA5 5 ILE B 242 LYS B 247 0 SHEET 2 AA5 5 VAL B 256 TRP B 261 -1 O GLU B 258 N HIS B 246 SHEET 3 AA5 5 VAL B 268 LEU B 273 -1 O VAL B 270 N TYR B 257 SHEET 4 AA5 5 PHE B 311 GLU B 316 -1 O PHE B 311 N LEU B 273 SHEET 5 AA5 5 LEU B 301 CYS B 305 -1 N GLY B 303 O ILE B 314 SHEET 1 AA6 2 PHE B 359 ILE B 360 0 SHEET 2 AA6 2 SER B 385 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 AA7 2 CYS B 369 VAL B 371 0 SHEET 2 AA7 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 AA8 2 TYR B 393 THR B 394 0 SHEET 2 AA8 2 LYS B 415 PHE B 416 -1 O PHE B 416 N TYR B 393 CISPEP 1 PRO A 309 PRO A 310 0 -1.69 CISPEP 2 PRO B 309 PRO B 310 0 -1.35 SITE 1 AC1 15 LEU A 248 ALA A 269 LYS A 271 PHE A 283 SITE 2 AC1 15 MET A 290 ILE A 313 THR A 315 GLU A 316 SITE 3 AC1 15 PHE A 317 MET A 318 THR A 319 TYR A 320 SITE 4 AC1 15 GLY A 321 LEU A 370 PHE A 382 SITE 1 AC2 6 HIS A 361 ASP A 363 ASN A 368 ALA A 380 SITE 2 AC2 6 PHE A 382 GLY A 383 SITE 1 AC3 6 ARG A 367 PRO A 402 ILE A 403 LYS A 404 SITE 2 AC3 6 TRP A 405 LEU A 445 SITE 1 AC4 10 ALA B 269 LYS B 271 ILE B 313 THR B 315 SITE 2 AC4 10 GLU B 316 PHE B 317 MET B 318 THR B 319 SITE 3 AC4 10 GLY B 321 PHE B 382 SITE 1 AC5 4 HIS B 361 ARG B 362 GLY B 383 SER B 385 SITE 1 AC6 5 ARG B 367 PRO B 402 ILE B 403 LYS B 404 SITE 2 AC6 5 LEU B 445 CRYST1 112.760 127.100 57.170 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008868 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007868 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017492 0.00000